Skip to content

ERC Pharma

Active
Public limited companyfounded 2023active for 2 yearsRue Jean Sonet,Isnes 10, 5032 Gembloux, BelgiumKBO/BCE: BE 1002.131.150
Summary

The computed 12-month bankruptcy probability of ERC Pharma is 2.4% (moderate). The 2025 annual accounts show negative equity (-€231,937) and a net result of -€179,975. Its solvency ranks better than 10% of 9,602 sector peers (NACE 46, financial year 2025). The company has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals.

Risk analysisFollow ReportCompare
ERC PharmaActiveChecked score 50/100
Risk analysis ReportCompare

Group and network

Connections & network

Depth

The network starts from this company’s shareholders. What else they own or run appears here as nodes.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.

We would like to set cookies. That happens only with your consent. What we measure